4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-21-029379
Director sold 200 shares at an average $25.17 ($5,034)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heyman Richard A. Director | 2021-04-28 | Sale | −100 | $25.08 | $2,508 | 227,300 | I: show line 1 in the form |
| Heyman Richard A. Director | 2021-04-30 | Sale | −100 | $25.26 | $2,526 | 227,200 | I: show line 2 in the form |
| Open-market sales · 200 sh · avg $25.17 · $5,034 | |||||||
Loading xslF345X03/doc4.xml…